Primary Mediastinal B-Cell Lymphoma (PMBCL) Overview
Learn About Primary Mediastinal B-Cell Lymphoma (PMBCL)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Vermont Medical Center Inc
Diego Adrianzen-Herrera is a Hematologist Oncology specialist and a Hematologist in Burlington, Vermont. Dr. Adrianzen-Herrera has been practicing medicine for over 14 years and is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Adrianzen-Herrera is currently accepting new patients.
Canton-Potsdam Hospital
Velmalia Matthews-Smith is a Hematologist Oncology specialist and an Oncologist in Potsdam, New York. Dr. Matthews-Smith and is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Familial Pancreatic Cancer. Dr. Matthews-Smith is currently accepting new patients.
John Griffin is a Hematologist Oncology specialist and an Oncologist in Plattsburgh, New York. Dr. Griffin and is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Breast Cancer, and Paget Disease of the Breast.
Summary: This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed primary mediastinal B-cell lymphoma (PMBCL). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of cancer cells to grow and spread. Treatment for P...
Summary: To study the safety and efficacy of cord blood-derived CD19 CAR-NK cells sequential with 7x19 CAR-T in relapse / refractory B cell lymphoma